Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice
<p>Abstract</p> <p>Background</p> <p>Depression guidelines in the UK recommended a policy of watchful waiting for mild depression due to a lack of evidence for the effectiveness of antidepressant treatment for mild cases. However there has been relatively little researc...
Main Authors: | Kendrick Tony, Chatwin Judy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-01-01
|
Series: | BMC Family Practice |
Online Access: | http://www.biomedcentral.com/1471-2296/8/2 |
Similar Items
-
Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice
by: Chatwin, Judy, et al.
Published: (2007) -
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study
by: T Kendrick, et al.
Published: (2009-04-01) -
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study
by: Kendrick, T., et al.
Published: (2009) -
Study protocol for the antidepressant advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care: a feasibility study
by: Allan H Young, et al.
Published: (2020-05-01) -
Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study)
by: I Nicol Ferrier, et al.
Published: (2015-06-01)